The transactivation process occurs rapidly after adding NTS to cancer cells, and when tyrosine1068 of the EGFR is phosphorylated, the MEK/ERK pathway is activated, leading to increased cancer cellular proliferation. The gene discussed is EGFR; the disease is cancer.